Abstract #313
Section: Physiology and Endocrinology (orals)
Session: Physiology and Endocrinology II
Format: Oral
Day/Time: Tuesday 10:45 AM–11:00 AM
Location: Lecture Hall
Session: Physiology and Endocrinology II
Format: Oral
Day/Time: Tuesday 10:45 AM–11:00 AM
Location: Lecture Hall
# 313
Evaluation of the biochemical and hematological profile of Holstein calves submitted to LPS challenge and pegbovigrastim injection.
Fernanda Kegles1, Otávio Madruga1, Lueli Fernandes Bragança1, Uriel Secco Londero1, Halfen Jessica1, Marcio Nunes Corrêa1, Francisco Augusto Burcklet Del Pino1, Eduardo Schmitt1, Rodrigo Chaves Barcellos Grazziotin*1, 1Federal University of Pelotas (UFPel), RS, Brazil; Center of Research, Teaching and Extension in Animal Science (NUPEEC), Pelotas, Rio Grande do Sul, Brazil.
Key Words: pegbovigrastim, immunity, paraoxonase (PON)
Evaluation of the biochemical and hematological profile of Holstein calves submitted to LPS challenge and pegbovigrastim injection.
Fernanda Kegles1, Otávio Madruga1, Lueli Fernandes Bragança1, Uriel Secco Londero1, Halfen Jessica1, Marcio Nunes Corrêa1, Francisco Augusto Burcklet Del Pino1, Eduardo Schmitt1, Rodrigo Chaves Barcellos Grazziotin*1, 1Federal University of Pelotas (UFPel), RS, Brazil; Center of Research, Teaching and Extension in Animal Science (NUPEEC), Pelotas, Rio Grande do Sul, Brazil.
The hypothesis of this study was that the exacerbated response of the innate immunity stimulated by pegbovigrastim when associated with a lipopolysaccharide challenge could negatively affect the liver, renal and protein metabolism of the dairy calves. Metabolic and hematological parameters were analyzed in dairy calves that recieved a dose of 0.25 μg/kg BW of E. coli lipopolysaccharide (LPS) associated with a dose of 25 μg/kg BW pegbovigrastim 24 h later. Twenty Holstein calves (D60 ± 15) were randomly distribued into 4 groups: LPS (n = 5) that received a single intravenous (IV) application of LPS (D0); PEG (n = 5), received a SC application of pegbovigrastim on d 1 (D1); PEG + LPS (n = 5), received a LPS injection D0 and pegbovigrastim at D1; and CTR group (n = 5), received a dose of 0.9% sodium chloride by IV at D0 and another SC dose at D1. For analysis of biochemical and hematological parameters, blood samples were collected on d −1, 0, 1, 2, 3, 4, 8, 14 and 21. The biochemical parameters analyzed were albumin, aspartate aminotransferase, creatinine, gamma glutamyl transferase, PPT, urea, C-reactive protein, haptoglobin and activity of the paraoxonase 1 (PON1). Total leukocyte counts and other hematological variables were also analyzed at the same sampling points. Outcomes were analyzed using a repeated-measures ANOVA (Proc MIXED, SAS Studio). The LPS, PEG, and LPS + PEG groups showed an increase in the number of total leukocytes (P < 0.0001) in relation to the CTR, and the PEG and LPS + PEG groups remained with the highest number of cells from d 2 to d 21. The concentration of PON1 was lower in LPS+PEG in comparison to PEG (P = 0.02), but not different to the other groups. Moreover, the LPS + PEG group had higher GGT (P = 0.0042) e lower AST (P < 0.0001) and urea (P = 0.02) concetration that the other groups. Althought some hepatic, renal and protein markers had been diferents in the LPS+ PEG these were maintained in physiological concentrations. The results demonstred that PEG injection even in LPS association increased the leukocytes for 21 d without compromising hepatic renal and protein metabolism.
Key Words: pegbovigrastim, immunity, paraoxonase (PON)